Funds advised by T. Rowe Price Associates, Fidelity Management & Research Company, Partner Fund Management, Warburg Pincus, Perceptive Advisors and The Vertical Group agreed to invest $76.5m in Outset Medical, medical technology provider. “We are very grateful to have outstanding support from T. Rowe Price and from our returning investors. Physicians and patients are excited about our technology, which meaningfully upgrades the patient’s treatment experience and offers a new avenue for cost reduction in a historically labour-intensive, infrastructure-intensive area of healthcare. This funding will provide the resources needed to scale our launch and brings us a step closer to making a significant and lasting impact on dialysis care.” Leslie Trigg, Outset Medical’s CEO.